Reaching the Last 20% (the Pamoja Kwa Afya Study)

Abroad (travel likely)Recruiting

Conditions

HIV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Impact Research and Development Organization (IRDO), Kisumu, Kenya
Contact: Study coordinator (Kawango Agot, PhD, MPH) · kawango@impact-rdo.org · +254 736 505046
Contact: Principal Investigator (Kawango Agot, PhD, MPH)

Study leads

Sue Napierala, PhD, MPH
Principal Investigator
RTI International

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Human Immunodeficiency Virus (HIV) · HIV Pre-Exposure Prophylaxis

Abroad (travel likely)RecruitingPHASE3

Homabay County, Kenya · Thika, Kenya

Intervention to Improve Parent Communication About Sexuality

HIV/STI Incidence · Communication About Health Information

Abroad (travel likely)Recruiting

Philadelphia, United States

Dental Management of Patients With HIV in Pays de la Loire

HIV Infection · Acquired Immune Deficiency Syndrome · Oral Health Care

Abroad (travel likely)Recruiting

Nantes, France

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

Hiv · Substance Use Disorders

Abroad (travel likely)Recruiting

Miami, United States · Boston, United States